{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T19:16:34Z","timestamp":1715714194785},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.mehy.2014.11.007","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T14:54:03Z","timestamp":1416236043000},"page":"14-19","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["How to mechanistically explain the CONDOR study data"],"prefix":"10.1016","volume":"84","author":[{"given":"C.M.","family":"Spies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Stemmler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Buttgereit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2014.11.007_b0005","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cgh.2007.03.011","article-title":"Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review","volume":"5","author":"Rostom","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.mehy.2014.11.007_b0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.amjmed.2005.09.054","article-title":"Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I study","volume":"119","author":"Singh","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.mehy.2014.11.007_b0015","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1185\/03007990802714382","article-title":"Pooled analysis of GI tolerability of 21 randomized controlled trials of celecoxib and nonselective NSAIDs","volume":"25","author":"Niculescu","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.mehy.2014.11.007_b0020","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(99)02332-6","article-title":"Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison","volume":"354","author":"Emery","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2014.11.007_b0025","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib long-term arthritis safety study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2014.11.007_b0305","first-page":"2398","article-title":"Reporting of 6-month vs 12-month data in a clinical trial of celecoxib","volume":"286","author":"Hrachovec","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2014.11.007_b0035","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1056\/NEJMoa021907","article-title":"Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis","volume":"347","author":"Chan","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2014.11.007_b0040","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.amjmed.2005.04.031","article-title":"Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications","volume":"118","author":"Lai","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.mehy.2014.11.007_b0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3899\/jrheum.090168","article-title":"A novel composite endpoint to evaluate the gastrointestinal (GI) effects of nonsteroidal antiinflammatory drugs through the entire GI tract","volume":"37","author":"Chan","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.mehy.2014.11.007_b0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(10)60673-3","article-title":"Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial","volume":"376","author":"Chan","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2014.11.007_b0055","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1365-2036.2007.03312.x","article-title":"Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy","volume":"25","author":"Goldstein","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mehy.2014.11.007_b0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1542-3565(04)00619-6","article-title":"Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo","volume":"3","author":"Goldstein","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.mehy.2014.11.007_b0065","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0002-9343(89)90344-6","article-title":"Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage","volume":"86","author":"Schoen","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.mehy.2014.11.007_b0070","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat New Biol"},{"key":"10.1016\/j.mehy.2014.11.007_b0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1476-5381.1977.tb07522.x","article-title":"Mechanisms underlying gastric mucosal damage induced by indomethacin and bile-salts, and the actions of prostaglandins","volume":"60","author":"Whittle","year":"1977","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2014.11.007_b0080","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs","volume":"340","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2014.11.007_b0085","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1021\/jm960803q","article-title":"Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib)","volume":"40","author":"Penning","year":"1997","journal-title":"J Med Chem"},{"key":"10.1016\/j.mehy.2014.11.007_b0090","doi-asserted-by":"crossref","first-page":"81s","DOI":"10.18433\/J3T886","article-title":"Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond","volume":"11","author":"Rao","year":"2008","journal-title":"J Pharm Pharm Sci"},{"issue":"Suppl. 19","key":"10.1016\/j.mehy.2014.11.007_b0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00535-008-2266-6","article-title":"Intestinal permeability in the pathogenesis of NSAID-induced enteropathy","volume":"44","author":"Bjarnason","year":"2009","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.mehy.2014.11.007_b0100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/ard.55.4.211","article-title":"A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity","volume":"55","author":"Mahmud","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.mehy.2014.11.007_b0105","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/003655200750023156","article-title":"Comparison of the intestinal toxicity of celecoxib, a selective COX-2 inhibitor, and indomethacin in the experimental rat","volume":"35","author":"Tibble","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.mehy.2014.11.007_b0110","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/gut.49.5.650","article-title":"Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs","volume":"49","author":"Smecuol","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.mehy.2014.11.007_b0115","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/1961323a0","article-title":"Ability of some antirheumatic drugs to uncouple oxidative phosphorylation","volume":"196","author":"Whitehouse","year":"1962","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2014.11.007_b0120","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/abbi.1996.0459","article-title":"In vitro interaction of nonsteroidal anti-inflammatory drugs on oxidative phosphorylation of rat kidney mitochondria: respiration and ATP synthesis","volume":"334","author":"Mingatto","year":"1996","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.mehy.2014.11.007_b0125","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.1780391208","article-title":"Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation","volume":"39","author":"Mahmud","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mehy.2014.11.007_b0130","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0006-2952(99)00163-X","article-title":"Diphenylamine as an important structure of nonsteroidal anti-inflammatory drugs to uncouple mitochondrial oxidative phosphorylation","volume":"58","author":"Masubuchi","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2014.11.007_b0135","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1046\/j.1365-2036.2000.00723.x","article-title":"Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat","volume":"14","author":"Somasundaram","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mehy.2014.11.007_b0140","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/gut.41.3.344","article-title":"Mitochondrial damage: a possible mechanism of the \u201ctopical\u201d phase of NSAID induced injury to the rat intestine","volume":"41","author":"Somasundaram","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.mehy.2014.11.007_b0145","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0005-2728(99)00058-4","article-title":"Effects of the mitogen concanavalin A on pathways of thymocyte energy metabolism","volume":"1412","author":"Krauss","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mehy.2014.11.007_b0150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02351215","article-title":"ConA induced changes in energy metabolism of rat thymocytes","volume":"12","author":"Buttgereit","year":"1992","journal-title":"Biosci Rep"},{"key":"10.1016\/j.mehy.2014.11.007_b0310","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1432-1033.1994.tb19020.x","article-title":"The effects of methylprednisolone on oxidative phosphorylation in Concanavalin-A-stimulated thymocytes. Top-down elasticity analysis and control analysis","volume":"223","author":"Buttgereit","year":"1994","journal-title":"Eur J Biochem\/FEBS"},{"key":"10.1016\/j.mehy.2014.11.007_b0160","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1517\/17425255.1.4.655","article-title":"Drug-induced mitochondrial toxicity","volume":"1","author":"Chan","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.mehy.2014.11.007_b0165","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1289\/ehp.9087213","article-title":"Uncouplers of oxidative phosphorylation","volume":"87","author":"Terada","year":"1990","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.mehy.2014.11.007_b0170","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/art.10969","article-title":"Nonsteroidal antiinflammatory drugs and a selective cyclooxygenase 2 inhibitor uncouple mitochondria in intact cells","volume":"48","author":"Krause","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mehy.2014.11.007_b0175","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/S0045-6535(98)00446-9","article-title":"Quantitative structure-activity relationships for the toxicity of chlorophenols to mammalian submitochondrial particles","volume":"38","author":"Argese","year":"1999","journal-title":"Chemosphere"},{"key":"10.1016\/j.mehy.2014.11.007_b0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(00)02463-6","article-title":"Therapeutic implications of non-genomic glucocorticoid activity","volume":"356","author":"Lipworth","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2014.11.007_b0185","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/A:1026445108136","article-title":"Bioenergetics of human peripheral blood mononuclear cell metabolism in quiescent, activated, and glucocorticoid-treated states","volume":"20","author":"Schmid","year":"2000","journal-title":"Biosci Rep"},{"key":"10.1016\/j.mehy.2014.11.007_b0190","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.bcp.2005.10.045","article-title":"Potencies of topical glucocorticoids to mediate genomic and nongenomic effects on human peripheral blood mononuclear cells","volume":"71","author":"Naumann","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2014.11.007_b0195","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0006-2952(99)00090-8","article-title":"Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy","volume":"58","author":"Buttgereit","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2014.11.007_b0200","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0005-2728(96)00109-0","article-title":"Uncoupling effects of diclofenac and aspirin in the perfused liver and isolated hepatic mitochondria of rat","volume":"1318","author":"Petrescu","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mehy.2014.11.007_b0205","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1002\/jps.21218","article-title":"Effect of nonsteroidal anti-inflammatory drugs on the cellular membrane fluidity","volume":"97","author":"Sousa","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.mehy.2014.11.007_b0210","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.aca.2007.06.039","article-title":"Use of liposomes to evaluate the role of membrane interactions on antioxidant activity","volume":"597","author":"Lucio","year":"2007","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.mehy.2014.11.007_b0215","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ab.2004.12.023","article-title":"Effect of anti-inflammatory drugs on splenocyte membrane fluidity","volume":"339","author":"Ferreira","year":"2005","journal-title":"Anal Biochem"},{"key":"10.1016\/j.mehy.2014.11.007_b0220","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/08982100903244492","article-title":"Concentration-dependent differing actions of the nonsteroidal anti-inflammatory drug, celecoxib, in distearoyl phosphatidylcholine multilamellar vesicles","volume":"20","author":"Sade","year":"2010","journal-title":"J Liposome Res"},{"key":"10.1016\/j.mehy.2014.11.007_b0225","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/mol.107.034009","article-title":"Cholesterol-like effects of selective cyclooxygenase inhibitors and fibrates on cellular membranes and amyloid-beta production","volume":"72","author":"Gamerdinger","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.mehy.2014.11.007_b0230","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1042\/BSR20100149","article-title":"Celecoxib reduces fluidity and decreases metastatic potential of colon cancer cell lines irrespective of COX-2 expression","volume":"32","author":"Sade","year":"2012","journal-title":"Biosci Rep"},{"key":"10.1016\/j.mehy.2014.11.007_b0235","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s00216-005-3251-z","article-title":"Effects of diclofenac on EPC liposome membrane properties","volume":"382","author":"Ferreira","year":"2005","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.mehy.2014.11.007_b0240","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.bbamem.2009.01.016","article-title":"The membrane-activity of ibuprofen, diclofenac, and naproxen: a physico-chemical study with lecithin phospholipids","volume":"1788","author":"Manrique-Moreno","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mehy.2014.11.007_b0245","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.atherosclerosis.2004.10.001","article-title":"Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs","volume":"177","author":"Walter","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mehy.2014.11.007_b0250","doi-asserted-by":"crossref","first-page":"13608","DOI":"10.1021\/jp304037v","article-title":"Interaction of celecoxib with membranes: the role of membrane biophysics on its therapeutic and toxic effects","volume":"116","author":"Pereira-Leite","year":"2012","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.mehy.2014.11.007_b0315","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1021\/la201600y","article-title":"NSAIDs interactions with membranes: a biophysical approach","volume":"27","author":"Nunes","year":"2011","journal-title":"Langmuir"},{"key":"10.1016\/j.mehy.2014.11.007_b0260","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00109-009-0506-8","article-title":"Cellular membranes function as a storage compartment for celecoxib","volume":"87","author":"Maier","year":"2009","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.mehy.2014.11.007_b0265","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s10620-006-3204-1","article-title":"Indomethacin enhances bile salt detergent activity: relevance for NSAIDs-induced gastrointestinal mucosal injury","volume":"51","author":"Petruzzelli","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.mehy.2014.11.007_b0270","first-page":"24","article-title":"Bile acids: the good, the bad, and the ugly","volume":"14","author":"Hofmann","year":"1999","journal-title":"News Physiol Sci"},{"key":"10.1016\/j.mehy.2014.11.007_b0275","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.clinbiochem.2007.01.015","article-title":"Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts","volume":"40","author":"Petruzzelli","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1016\/j.mehy.2014.11.007_b0280","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0016-5085(83)90143-9","article-title":"Aspirin can inhibit gastric mucosal cyclo-oxygenase without causing lesions in rat","volume":"84","author":"Ligumsky","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mehy.2014.11.007_b0285","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/bjs.1800620208","article-title":"Decreased incidence of indomethacin-induced gastric ulceration in rats by bile duct diversion","volume":"62","author":"Abtahi","year":"1975","journal-title":"Br J Surg"},{"key":"10.1016\/j.mehy.2014.11.007_b0290","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1053\/gast.1997.v112.pm9178685","article-title":"Deranged hydrophobic barrier of the rat gastroduodenal mucosa after parenteral nonsteroidal anti-inflammatory drugs","volume":"112","author":"Lugea","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mehy.2014.11.007_b0295","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0016-5085(00)70371-4","article-title":"Role of biliary phosphatidylcholine in bile acid protection and NSAID injury of the ileal mucosa in rats","volume":"118","author":"Barrios","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mehy.2014.11.007_b0300","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1016\/j.bbamem.2012.07.029","article-title":"Aggregation behavior of ibuprofen, cholic acid and dodecylphosphocholine micelles","volume":"1818","author":"Prakash","year":"2012","journal-title":"Biochim Biophys Acta"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714004034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714004034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T09:53:39Z","timestamp":1566035619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987714004034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0306987714004034"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2014.11.007","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to mechanistically explain the CONDOR study data","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2014.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}